<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">A recent systematic review of clinical trials utilising chloroquine or hydroxychloroquine [
 <xref rid="bib74" ref-type="bibr">74</xref>] concluded that 5/7 trials had shown favorable outcomes for patients using these drugs and 2/7 demonstrated no significant change compared to control. It was noted that all 7 trials carried varying degrees of poor study design and bias. One such study, a pilot observational study [
 <xref rid="bib93" ref-type="bibr">93</xref>] showed that use of hydroxychloroquine and azithromycin demonstrated apparent improved clinical outcomes in 65/80 patients, expanding earlier work suggesting that combined therapy resulted in rapid reduction in viral load. Clearly, more robust clinical studies are needed and have been called for [
 <xref rid="bib74" ref-type="bibr">74</xref>].
</p>
